Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
  • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
  • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
  • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
  • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
  • C07D213/30—Oxygen atoms
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
  • C07C223/06—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
  • C07C251/32—Oximes
  • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
  • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
  • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
  • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
  • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D231/16—Halogen atoms or nitro radicals
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
  • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
  • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Definitions

• the present invention relates to new pyrazolylbiphenylcarboxamides, several processes for their preparation and their use for controlling unwanted microorganisms.
• R 1 represents hydrogen, -Ce-alkyl, C] -C 6 -haloalkyl, benzyl or pyridylmethyl,
• R 2 represents hydrogen or dC 6 alkyl
• Halogen atoms C 2 -C 8 alkenyloxy, C 2 -C 8 alkynyloxy, C 3 -C 8 cycloalkyl, Ci-C ⁇ -alkoxycarb ⁇ nyl or represents -CCR ⁇ NO 1 ,
• n represents integers from 0 to 3, where X represents identical or different radicals if m represents 2 or 3,
• Y for halogen, nitro, cyano, hydroxy, carboxyl, -Cs-alkyl, - -halo-alkyl with 1 to 5 halogen atoms, - -alkoxy, - -haloalkoxy with 1 to 5 halogen atoms, CrC 8 -alkylthio, CrC ⁇ -haloalkylthio with 1 to 5 halogen atoms, C 2 -C 8 alkenyloxy, C 2 -C 8 alkynyloxy, C 3 -C 8 cycloalkyl, -Cs-alkoxycarbonyl or CrC ⁇ -Alkoximino- -Ce-alkyl, and
• n stands for integers from 0 to 4, where Y stands for identical or different radicals if n stands for 2, 3 or 4,
• G represents halogen, hydroxy or CrC 6 alkoxy
• R, ⁇ , R, Y and n have the meanings given above and
• G 1 and G 2 each represent hydrogen or together represent tetramethylethylene
• G 1 and G 2 each represent hydrogen or together represent tetramethylethylene
• R, ⁇ , R, Y and n have the meanings given above,
• R 2 , X, m, Y and n have the meanings given above and
• R 2 , X, m, Y and n have the meanings given above,
• E represents chlorine, bromine, iodine, methanesulfonyl or p-toluenesulfonyl
• R and E together are (di-CrC ⁇ ⁇ -alky sulfate
• R 1 , R 2 , Y and n have the meanings given above,
• Formula (I) has very good microbicidal properties and can be used to control unwanted microorganisms both in crop protection and in material protection.
• the pyrazolylbiphenylcarboxamides of the formula (I) according to the invention have a substantially better fungicidal activity than the constitutionally most similar, known active substances of the same direction of action.
• the pyrazolylbiphenylcarboxamides according to the invention are generally defined by the formula (I).
• R 1 preferably represents hydrogen, - alkyl, C 1 -C 2 haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms, benzyl or pyridylmethyl.
• R 2 preferably represents hydrogen or Ci-Gt-alkyl.
• X preferably represents fluorine, chlorine, bromine, nitro, cyano, hydroxyl, carboxyl, -C ö alkyl, C 1 -C 2 haloalkyl having 1 to 5 fluorine, chlorine and / or
• Bromine atoms, d-Cö-alkoxy, C 1 -C 2 haloalkoxy with 1 to 5 fluorine, chlorine and / or bromine atoms, -Cö-AUjylthio, C 1 -C 2 haloalkylthio with 1 to 5 Fluorine, chlorine and / or bromine atoms, C 2 -C 6 alkenyloxy, C 2 -C 6 alkynyloxy, C 3 -C 7 cycloalkyl, -Q-alkoxycarbonyl or for -C (R 2 ) N-OR ! ,
• n preferably represents integers from 0 to 3, where X represents identical or different radicals if m represents 2 or 3.
• Y preferably represents fluorine, chlorine, bromine, nitro, cyano, hydroxy, carboxyl, CrC ⁇ -alkyl, C 1 -C 2 -haloalkyl with 1 to 5 fluorine, chlorine and / or bromine atoms, CrC ⁇ -alkoxy, C 1 -C 2 haloalkoxy with 1 to 5 fluorine, chlorine and / or bromine atoms, -Cg-alkylthio, C] -C -haloalkylthio with 1 to 5
• n is preferably an integer from 0 to 3, where Y is the same or different radicals if n is 2 or 3.
• R 1 particularly preferably represents hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, s-butyl, t-butyl, 2-chloroethyl, benzyl, 2-pyridylmethyl, 3-pyridylmethyl or 4-pyridylmethyl.
• R 2 particularly preferably represents hydrogen, methyl, ethyl, n-propyl, i-propyl or n-butyl.
• X particularly preferably represents fluorine, chlorine, bromine, nitro, cyano, hydroxy
• Carboxyl methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, i-butyl, tert-butyl, trichloromethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, methoxy, ethoxy, difluoromethoxy, trifluoromethoxy, methylthio, Trifluoromethylthio, difluorochloromethylthio, allyloxy, propargyloxy, cyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl, methoxycarbonyl,
• Ethoxycarbonyl or for -C (R 2 ) N-OR 1 .
• m particularly preferably represents integers from 0 to 2, where X represents the same or different radicals if m represents 2.
• Y particularly preferably represents fluorine, chlorine, bromine, nitro, cyano, hydroxy, carboxyl, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, i-butyl, tert-butyl, trichloromethyl, trifluoromethyl , Difluoromethyl, difluorochloromethyl, methoxy, ethoxy, difluoromethoxy, trifluoromethoxy, methylthio, trifluoromethylthio, difluorochloromethylthio, allyloxy, propargyloxy, cyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl, methoxycarbonyl, methoxymethylcarbonyl
• n particularly preferably represents integers from 0 to 2, where Y represents identical or different radicals if n represents 2.
• R, R, X, m, Y and n have the meanings given above.
• Compounds of the formula (Ib) in which R 1 , R 2 , X, m, Y and n have the meanings given above as preferred or particularly preferred are particularly preferred.
• R, ⁇ , R, X, m, Y and n have the meanings given above.
• R, 1, ⁇ R> 2 X, m, Y and n have the meanings given above. Particular preference is given to compounds of the formula (Id) in which R, R, X, m, Y and n have the meanings given above as preferred or particularly preferred.
• Preferred or particularly preferred are compounds which carry the substituents mentioned under preferred or particularly preferred.
• Saturated or unsaturated hydrocarbon radicals such as alkyl or alkenyl can also be used in connection with heteroatoms, e.g. in alkoxy, where possible, be straight-chain or branched.
• Optionally substituted radicals can be mono- or polysubstituted, whereby in the case of multiple substitutions the substituents can be the same or different.
• residues with the same indices such as m residues X for m> 1, can be the same or different.
• Halogen-substituted radicals e.g. Haloalkyl
• Halogen-substituted radicals are halogenated once or several times. In the case of multiple halogenation, the halogen atoms can be the same or different.
• Halogen stands for fluorine, chlorine, bromine and iodine, in particular for fluorine, chlorine and bromine.
• Formula (II) provides a general definition of the carboxylic acid derivatives required as starting materials when carrying out process (a) according to the invention.
• G preferably represents chlorine, bromine, hydroxy, methoxy or ethoxy, particularly preferably chlorine, hydroxy or methoxy.
• the carboxylic acid derivatives of the formula (II) are known or can be prepared by known processes (cf. WO 93/11 117, EP-A 0 545 099, EP-A 0 589 301 and EP-A 0 589 313).
• the formula (TU) provides a general definition of the aniline derivatives required as reaction components when carrying out process (a) according to the invention.
• R 1 , R 2 , X, m, Y and n preferably have those meanings which are already in connection with the description of the substances according to the invention of the formula (I) were preferred or particularly preferred for these radicals or these indices.
• aniline derivatives of the formula (III) are new. Some of them can be produced by known methods (cf. EP-A 0 545 099 and EP-A 0 589 301).
• R 1 , R 2 , Y, n, G 1 and G 2 have the meanings given above, if appropriate in the presence of an acid binder and if appropriate in the presence of an inert organic diluent and if appropriate in the presence of a catalyst
• Formula (XI) provides a general definition of the 2-haloaniline derivatives required as reaction components when carrying out process (g) according to the invention.
• X and m preferably have those meanings which have already been mentioned in connection with the description of the substances of the formula (I) according to the invention or are particularly preferred for these radicals or these indices.
• Shark is preferably fluorine, chlorine or bromine, particularly preferably chlorine or bromine.
• the 2-haloaniline derivatives of the formula (XI) are commercially available or can be prepared from the corresponding nitro compounds by reduction.
• Formula (XII) provides a general definition of the aniline boronic acids required as reaction components when carrying out process (h) according to the invention.
• X and m preferably have those meanings that already in connection with the description of the substances of the invention
• G 1 and G 2 each preferably represent hydrogen or together represent tetramethylethylene.
• aniline boronic acids of the formula (XII) are commercially available.
• Formula (IV) provides a general definition of the carboxamide derivatives required as starting materials when carrying out processes (b) and (f) according to the invention.
• X and m preferably represent those meanings which are already in connection with the description of the invention
• the carboxamide derivatives of the formula (TV) are known or can be prepared by known processes (cf. WO 91/01311, EP-A 0371 950).
• Formula (V) provides a general definition of the boronic acid derivatives required as reaction components when carrying out process (b) and process (g) according to the invention.
• R 1 , R 2 , Y and n preferably have those meanings which have already been mentioned in connection with the description of the substances of the formula (I) according to the invention or are particularly preferred for these radicals or these indices.
• the boronic acid derivatives of the formula (V) are new and can be prepared by
• R 2 , Y, n, G 1 and G 2 have the meanings given above,
• R 1 has the meanings given above,
• Formula (XHI) provides a general definition of the phenylboronic acids required as reaction components when carrying out process (h) according to the invention.
• R 2 , Y and n preferably have those meanings which, in connection with the description of the substances of the formula (I) according to the invention, are preferred or particularly preferred for these radicals or these
• G and G are preferably each hydrogen or together tetramethylethylene.
• the phenylboronic acids of the formula (XHI) are commercially available.
• Formula (VI) provides a general definition of the carboxamide-boronic acid derivatives required as reaction components when carrying out process (c) according to the invention.
• X and m preferably represent those meanings which have already been mentioned as preferred or particularly preferred for these radicals in connection with the description of the substances of the formula (I) according to the invention.
• G 1 and G 2 each preferably represent hydrogen or together represent tetramethylethylene.
• the carboxamide-boronic acid derivatives of the formula (VI) are new. They can be made by
• Formula (VH) provides a general definition of the phenyloxime derivatives required as reaction components when carrying out processes (c), (f) and (h) according to the invention.
• R 1 , R 2 , Y and n preferably represent those meanings which have already been mentioned as preferred or particularly preferred for these radicals in connection with the description of the substances of the formula (I) according to the invention.
• the phenyloxime derivatives of the formula (VII) are known or can be prepared by known processes (cf. Synth. Commun. 2000, 30, 665-669, Synth. Commun. 1999, 29, 1697-1701).
• Formula (ViH) provides a general definition of the biphenylacyl derivatives required as starting materials when carrying out process (d) according to the invention.
• R 2 , X, m, Y and n have the meanings which have already been mentioned as preferred or particularly preferred for these radicals in connection with the description of the substances of the formula (I) according to the invention.
• the biphenylacyl derivatives of the formula CVT) are new. They can be made by
• R, X, m, Y and n have the meanings given above,
• Formula (XTV) provides a general definition of the 2-benzaldehyde aniline derivatives required as reaction components when carrying out process (k) according to the invention.
• R 2 , X, m, Y and n preferably have those meanings which have already been mentioned as preferred or particularly preferred for these radicals in connection with the description of the substances of the formula (I) according to the invention.
• the 2-benzaldehyde aniline derivatives of the formula (XTV) are new. They can be made by
• Formula (IX) provides a general definition of the alkoxamines required as reaction components when carrying out process (d) and process (i) according to the invention.
• R 1 preferably has those meanings which have already been mentioned in connection with the description of the substances of the formula (I) according to the invention or have been particularly preferred for this radical.
• the hydrochlorides specified in the description are preferably used.
• the free alkoxamines can also be used in the process according to the invention.
• the alkoxamines of the formula (IX) are commercially available.
• Formula (I-a) provides a general definition of the hydroxylamine derivatives required as starting materials when carrying out process (e) according to the invention.
• R, X, m, Y and n preferably represent those meanings which have already been mentioned as preferred or particularly preferred for these radicals in connection with the description of the substances of the formula (I) according to the invention.
• hydroxylamine derivatives of the formula (I-a) according to the invention are new. They can be prepared using one of the processes (a), (b), (c),
• Formula (X) provides a general definition of the compounds required as reaction components when carrying out process (e) according to the invention.
• R 3 preferably represents C 1 -C 4 alkyl, particularly preferably methyl,
• E preferably represents chlorine, bromine, iodine, Methanesulfonyl or p-toluenesulfonyl.
• Suitable acid binders for carrying out processes (a), (b), (c), (d), (e) and (f) are all inorganic and organic bases customary for such reactions.
• Alkaline earth or alkali metal hydroxides such as sodium hydroxide, calcium hydroxide, potassium hydroxide, or also ammonium hydroxide, alkali metal carbonates, such as, are preferably usable
• Sodium carbonate, potassium carbonate, potassium hydrogen carbonate, sodium hydrogen carbonate, alkali or alkaline earth metal acetates such as sodium acetate, potassium acetate, calcium acetate, and also tertiary amines, such as trimethylamine, triethylamine, tributylamine, N, N-dimethylaniline, pyridine, N-methylpiperidine, N, N- Dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclonones (DBN) or diazabicycloundecene
• DABCO diazabicyclooctane
• DBN diazabicyclonones
• DBN diazabicycloundecene
• Suitable diluents for carrying out processes (a), (b), (c), (d), (e) and (f) are all customary inert, organic solvents.
• Halogenated aliphatic, alicyclic or aromatic hydrocarbons such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; Chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane; Ethers, such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; Nitriles, such as
• reaction temperatures can each be varied within a substantial range when carrying out processes (a), (b), (c), (d), (e) and (f). In general, temperatures between 0 ° C and 140 ° C, preferably between 10 ° C and 120 ° C.
• the procedure is generally in each case under atmospheric pressure. However, it is also possible to work under increased or reduced pressure.
• 1 mole of carboxamide-boronic acid derivative of the formula (VI) is generally 1 mole or an excess of phenyloxime derivative of the formula (VII) and 1 to 10 moles of acid binder and 0.5 to 5 mole percent of a catalyst.
• the reaction components in other ratios.
• the processing takes place according to usual methods. In general, the procedure is such that water is added to the reaction mixture, the precipitate is separated off and dried. The remaining residue can, if appropriate, be freed of any impurities which may still be present, using customary methods, such as chromatography or recrystallization.
• Biphenylacyl derivative of the formula (VIII) in general 1 mol or an excess of alkoxamine of the formula (IX) and 1 to 5 mol of acid binder.
• reaction components in other ratios.
• the processing takes place according to usual methods. In general, the procedure is such that water is added to the reaction mixture, the precipitate is separated off, washed with water and diisopropyl ether and then dried. The remaining residue can, if appropriate, be freed of any impurities which may still be present, using customary methods, such as chromatography or recrystallization.
• Carboxamide derivative of the formula (IV) generally 1 mol or an excess of phenyloxime derivative of the formula (VIT) and 1 to 5 mol of acid binder and 1 to 5 mol of a catalyst.
• reaction components in other ratios.
• the processing takes place according to usual methods. In general, the procedure is such that water is added to the reaction mixture, the precipitate is separated off and dried. The remaining residue can, if appropriate, be freed of any impurities which may still be present, using customary methods, such as chromatography or recrystallization.
• the substances according to the invention have a strong microbicidal action and can be used to control unwanted microorganisms, such as fungi and bacteria, in crop protection and in material protection.
• Fungicides can be used to control Plasmodiophoromycetes
• Bactericides can be used in crop protection to combat Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.
• Xanthomonas species such as, for example, Xanthomonas campestris pv. Oryzae
• Pseudomonas species such as, for example, Pseudomonas syringae pv. Lachrymans
• Erwinia species such as, for example, Erwinia amylovora;
• Pythium species such as, for example, Pythium ultimum
• Phytophthora species such as, for example, Phytophthora infestans
• Pseudoperonospora species such as, for example, Pseudoperonospora humuli or
• Plasmopara species such as, for example, Plasmopara viticola
• Bremia species such as, for example, Bremia lactucae
• Peronospora species such as, for example, Peronospora pisi or P. brassicae
• Erysiphe species such as, for example, Erysiphe graminis
• Sphaerotheca species such as, for example, Sphaerotheca fuliginea
• Podosphaera species such as, for example, Podosphaera leucotricha
• Venturia species such as, for example, Venturia inaequalis
• Pyrenophora species such as, for example, Pyrenophora teres or P. graminea (conidial form: Drechslera, Syn: Helminthosporium);
• Cochliobolus species such as, for example, Cochliobolus sativus
• Drechslera (Conidial form: Drechslera, Syn: Helminthosporium);
• Uromyces species such as, for example, Uromyces appendiculatus
• Puccinia species such as, for example, Puccinia recondita
• Sclerotinia species such as, for example, Sclerotinia sclerotiorum
• Tilletia species such as, for example, Tilletia caries
• Ustilago species such as, for example, Ustilago nuda or Ustilago avenae;
• Pellicularia species such as, for example, Pellicularia sasakii;
• Pyricularia species such as, for example, Pyricularia oryzae
• Fusarium species such as, for example, Fusarium culmorum
• Botrytis species such as, for example, Botrytis cinerea
• Septoria species such as, for example, Septoria nodorum
• Leptosphaeria species such as, for example, Leptosphaeria nodorum;
• Cercospora species such as, for example, Cercospora canescens; Alternaria species, such as, for example, Alternaria brassicae;
• Pseudocercosporella species such as, for example, Pseudocercosporella herpotrichoides.
• the fact that the active compounds are well tolerated by plants in the concentrations required to combat plant diseases permits treatment of above-ground parts of plants, of propagation stock and seeds, and of the soil.
• the active compounds according to the invention can be used particularly successfully to combat diseases in wine, fruit and vegetable cultivation, such as, for example, against Venturia, Botrytis, Sclerotinia, Rhizoctonia, Uncinula, Sphaerotheca, Podosphaera, Alternaria and Colletotrichum species. Rice diseases such as Pyricularia and Pellicularia species are also successfully combated.
• the active compounds according to the invention are also suitable for increasing the crop yield. They are also less toxic and have good plant tolerance.
• plants and parts of plants can be treated.
• Plants are understood here to mean all plants and plant populations, such as desired and undesirable wild plants or crop plants (including naturally occurring crop plants).
• Cultivated plants can be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant cultivars which can or cannot be protected by plant breeders' rights.
• Plant parts are to be understood to mean all above-ground and underground parts and organs of the plants, such as sprout, leaf, flower and root, by way of example
• Leaves, needles, stems, stems, flowers, fruiting bodies, fruits and seeds as well as roots, tubers and rhizomes are listed.
• the plant parts also include crops and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, offshoots and seeds.
• the substances according to the invention can be used to protect technical materials against attack and destruction by undesired microorganisms.
• technical materials which are to be protected against microbial change or destruction by active substances according to the invention can be adhesives, glues, paper and cardboard, textiles, leather, wood, paints and plastic articles, cooling lubricants and other materials which can be attacked or decomposed by microorganisms .
• parts of production plants for example cooling water circuits, are also mentioned which can be impaired by the multiplication of microorganisms.
• technical materials are preferably adhesives, glues, papers and cartons, leather, wood, paints, cooling lubricants and heat transfer fluids, particularly preferably wood.
• Bacteria, fungi, yeasts, algae and mucilaginous organisms may be mentioned as microorganisms which can cause degradation or a change in the technical materials.
• the active compounds according to the invention preferably act against fungi, in particular mold, wood-discoloring and wood-destroying fungi (Basidiomycetes) and against mucus organisms and algae.
• microorganisms of the following genera may be mentioned:
• Alternaria such as Alternaria tenuis
• Aspergillus such as Aspergillus niger
• Chaetomium like Chaetomium globosum
• Coniophora such as Coniophora puetana
• Lentinus such as Lentinus tigrinus
• Penicillium such as Penicillium glaucum
• Polyporus such as Polyporus versicolor
• Aureobasidium such as Aureobasidium pullulans
• Sclerophoma such as Sclerophoma pityophila
• Trichoderma such as Trichoderma viride
• Escherichia such as Escherichia coli
• Pseudomonas such as Pseudomonas aeruginosa
• Staphylococcus such as Staphylococcus aureus.
• the active ingredients can be converted into the customary formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols, very fine encapsulations in polymeric substances and in coating compositions for seeds, and ULV -Cold and warm mist formulations.
• formulations are made in a known manner, e.g. by mixing the active ingredients with extenders, that is to say liquid solvents, pressurized liquefied gases and / or solid carriers, if appropriate using surface-active agents, that is to say emulsifiers and / or dispersants and / or foam-generating agents. If water is used as an extender, e.g. organic solvents can also be used as auxiliary solvents.
• extenders that is to say liquid solvents, pressurized liquefied gases and / or solid carriers, if appropriate using surface-active agents, that is to say emulsifiers and / or dispersants and / or foam-generating agents.
• surface-active agents that is to say emulsifiers and / or dispersants and / or foam-generating agents.
• water e.g. organic solvents can also be used as auxiliary solvents.
• liquid solvents aromatics such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chlorethylenes or methylene chloride, aliphatic hydrocarbons such as cyclohexane or paraffins, e.g. Petroleum fractions, alcohols, such as butanol or glycol, and their ethers and
• esters such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents, such as dimethylformamide and dimethyl sulfoxide, and water.
• Liquefied gaseous extenders or carriers mean liquids which are gaseous at normal temperature and under normal pressure, for example aerosol propellants, such as halogenated hydrocarbons and butane, propane, nitrogen and carbon dioxide.
• aerosol propellants such as halogenated hydrocarbons and butane, propane, nitrogen and carbon dioxide.
• solid carriers come into question: for example natural rock powders such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth and synthetic rock powders such as highly disperse silica, aluminum oxide and silicates.
• Solid carrier materials for granules come into question: eg broken and fractionated natural rocks such as calcite, marble, pumice
• Granules from inorganic and organic flours as well as granules from organic material such as sawdust, coconut shells, corn cobs and tobacco stems.
• Possible emulsifiers and / or foaming agents are: e.g. non-ionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, e.g. Alkylaryl polyglycol ethers, alkyl sulfonates,
• Alkyl sulfates, aryl sulfonates and protein hydrolyzates Possible dispersants are: e.g. Lignin sulfite liquor and methyl cellulose.
• Adhesives such as carboxymethyl cellulose, natural and synthetic powdery, granular or latex-shaped polymers, such as gum arabic, polyvinyl alcohol, polyvinyl acetate, and also natural phospholipids, such as cephalins and lecithins, and synthetic phospholipids can be used in the formulations.
• Other additives can be mineral and vegetable oils.
• Dyes such as inorganic pigments, e.g. Iron oxide, titanium oxide, ferrocyan blue and organic dyes such as alizarin, azo and metal phthalocyanine dyes and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc can be used.
• the formulations generally contain between 0.1 and 95 percent by weight
• Active ingredient preferably between 0.5 and 90%.
• the active compounds according to the invention can also be used in a mixture with known fungicides, bactericides, acaricides, nematicides or insecticides, in order, for example, to broaden the activity spectrum or to prevent the development of resistance. In many cases you get it synergistic effects, ie the effectiveness of the mixture is greater than the effectiveness of the individual components.
• Diethofencarb Difenoconazol, Dimethirimol, Dimethomorph, Diniconazol, Diniconazol-M, Dinocap, Diphenylamin, Dipyrithione, Ditalimfos, Dithianon, Dode- morph, Dodine, Drazoxolon, Ediphenphos, Epoxiconazol, Etaconazol, Ethidimolol
• Flusilazole Flusilazole, flusulfamide, flutolanil, flutriafol, folpet, fosetyl-aluminum, fosetyl sodium, falidide, fuberidazole, furalaxyl, furametpyr, furcarbonil, furconazole,
• Mancopper Mancozeb, Maneb, Meferimzone, Mepanipyrim, Mepronil, Metalaxyl, Metconazol, Methasulfocarb, Methfuroxam, Metiram, Metomeclam, Metsulfovax,
• Oxadixyl Oxamocarb, Oxolinicacid, Oxycarboxim, Oxyfenthiin,
• Paclobutrazole pefurazoate, penconazole, pencycuron, phosdiphen, pimaricin, piperalin, polyoxin, polyoxorim, probenazole, prochloraz, procymidon, propamocarb,
• Thicyofen Thifluzamide, Thiophanate-methyl, Thiram, Tioxymid, Tolclofos-methyl,
• Tricyclazole tridemorph, triflumizole, triforin, triticonazole,
• N-formyl-N-hydroxy-DL-alanine sodium salt O, O-diethyl- [2- (dipropylamino) -2-oxoethyl] ethylphosphoramidothioate,
• Chloethocarb Chlorethoxyfos, Chlorfenapyr, Chlorfenvinphos, Chlorfluazuron, Chlormephos, Chlo ⁇ yrifos, Chlo ⁇ yrifos M, Chlovaphorthrin, Cis-Resmethrin, Cispermethrin, Clocythrin, Cloethocarb, Clofentezine, Cyanophoputhrin, Cycloprin, Cycloprin, Cycloprin M, Demeton S, Demeton-S-methyl, Diafenthiuron, Diazinon,
• Fenoxycarb Fenpropathrin, Fenpyrad, Fenpyrithrin, Fenpyroximate, Fenvalerate, Fipronil, Fluazinam, Fluazuron, Flubrocythrinate, Flucycloxuron, Flucythrinate, Flufenoxuron, Flutenzine, Fluvalinate, Fonophos, Fosmethxate, Granulirosfiriazolate, FostiHirosililan, Fosti Carburetone
• Halofenozide HCH, Heptenophos, Hexaflumuron, Hexythiazox, Hydroprene, Imidacloprid, isazophos, isofenphos, isoxathion, ivermectin,
• Metolcarb Metoxadiazone, Mevinphos, Milbemectin, Monocrotophos,
• Paecilomyces fumosoroseus Parathion A, Parathion M, Permethrin, Phenthoat, Phorat, Phosalon, Phosmet, Phosphamidon, Phoxim, Pirimicarb, Pirimiphos A,
• Pirimiphos M Profenophos, Promecarb, Propoxur, Prothiophos, Prothoat,
• Triarathenes triazamates, triazophos, triazuron, trichlophenidines, trichlorfon,
• Bacillus thuringiensis strain EG-2348 Bacillus thuringiensis strain EG-2348,
• the compounds of formula (I) according to the invention also have very good antifungal effects. They have a very broad one antifungal activity spectrum, in particular against dermatophytes and sprout fungi, mold and diphasic fungi,
• Candida species such as Candida albicans, Candida glabrata, Epidermophyton species such as Epidermophyton floccosum, Aspergillus species such as Aspergillus niger and Aspergillus fumigatus, Trichophyton species such as Trichophyton mentagrophytes, Microsporon canis and Microsporoni species such as Microsporoni.
• Candida species such as Candida albicans, Candida glabrata, Epidermophyton species such as Epidermophyton floccosum, Aspergillus species such as Aspergillus niger and Aspergillus fumigatus, Trichophyton species such as Trichophyton mentagrophytes, Microsporon canis and Microsporoni species such as Microsporoni.
• Candida species such as Candida albicans, Candida glabrata
• Epidermophyton species such as Epidermophyton floccosum
• Aspergillus species such as Aspergillus niger and Aspergillus fumigatus
• the active compounds can be used as such, in the form of their formulations or the use forms prepared therefrom, such as ready-to-use solutions, suspensions, wettable powders, pastes, soluble powders, dusts and granules. They are used in the usual way, e.g. by pouring, spraying, atomizing, scattering, dusting, foaming, brushing, etc. It is also possible to apply the active ingredients by the ultra-low-volume process or to inject the active ingredient preparation or the active ingredient into the soil itself. The seeds of the plants can also be treated.
• the application rates can be varied within a relatively wide range, depending on the type of application.
• the active compound application rates are generally between 0.1 and 10,000 g / ha, preferably between 10 and 1,000 g / ha.
• the active compound application rates are generally between 0.001 and 50 g per kilogram of seed, preferably between 0.01 and 10 g per kilogram of seed.
• the active compound application rates are generally between 0.1 and 10,000 g / ha, preferably between 1 and 5,000 g / ha.
• the agents used to protect industrial materials generally contain the active ingredients in an amount of 1 to 95%, preferably 10 to 75%.
• the application concentrations of the active compounds according to the invention depend on the type and the occurrence of the microorganisms to be controlled and on the composition of the material to be protected.
• the optimal amount can be determined by test series.
• the application concentrations are in the range from 0.001 to 5% by weight, preferably from 0.05 to 1.0% by weight, based on the material to be protected.
• the effectiveness and the spectrum of activity of the active ingredients to be used according to the invention in the protection of materials or of the agents, concentrates or very generally formulations which can be produced therefrom can be increased if further antimicrobial compounds, fungicides, bactericides, herbicides, insecticides or other active ingredients are used to enlarge the spectrum of activity or
• reaction mixture is stirred in 150 ml of water, extracted with ethyl acetate and dried over sodium sulfate. The organic phase is concentrated under reduced pressure and the solid residue is stirred in diisopropyl ether. 0.25 g (46% of theory) of 5-fluoro-1,3-dimethyl-N- [2- (4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2- yl) phenyl] -lH-pyrazole-4-carboxamide in the form of crystals of melting point 100 to 103 ° C.
• the determination is carried out in the acidic range at pH 2.3 with 0.1% aqueous phosphoric acid and acetonitrile as eluents; linear gradient from 10% acetonitrile to 90% acetonitrile (marked with a in the table).
• the determination is carried out in the neutral range at pH 7.5 with 0.01 molar aqueous
• the calibration is carried out with unbranched alkan-2-ones (with 3 to 16 carbon atoms), the logP values of which are known (determination of the logP values on the basis of the retention times by linear interpolation between two successive alkanes).
• the lambda max values were determined using the UV spectra from 200 nm to 400 nm in the maxima of the chromatographic signals.
• dimethylacetamide emulsifier 1.0 part by weight of alkyl aryl polyglycol ether
• active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration.
• Evaluation is carried out 10 days after the inoculation. 0% means an efficiency that corresponds to that of the control, while an efficiency of 100% means that no infection is observed.
• dimethylacetamide emulsifier 1.0 part by weight of alkyl aryl polyglycol ether
• active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration.
• Evaluation is carried out 10 days after the inoculation. 0% means an efficiency that corresponds to that of the control, while an efficiency of 100% means that no infection is observed.
• dimethylacetamide emulsifier 1.0 part by weight of alkyl aryl polyglycol ether
• active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration.
• Apple scab pathogen Venturia inaequalis and then remain in an incubation cabin for 1 day at approx. 20 ° C and 100% relative humidity.
• the plants are then placed in a greenhouse at approx. 21 ° C and a relative humidity of approx. 90%.
• Evaluation is carried out 12 days after the inoculation. 0% means an efficiency that corresponds to that of the control, while an efficiency of 100% means that no infection is observed.
• Emulsifier 0.6 part by weight of alkylaryl polyglycol ether
• active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration.
• the plants are then placed in a greenhouse at a temperature of approximately 20.degree. C. and a relative atmospheric humidity of 80% in order to promote the development of rust pustules.
• Evaluation is carried out 10 days after the inoculation. 0% means an efficiency that corresponds to that of the control, while an efficiency of 100% means that no infection is observed.
• Emulsifier 1 part by weight of alkylaryl polyglycol ether
• active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration.
• Evaluation is carried out 7 days after the inoculation. 0% means an efficiency that corresponds to that of the control, while an efficiency of 100% means that no infection is observed.
• Table E Altemaria test (tomato) / protective
• Lentinus tigrinus and Coriolus versicolor were excised from mycelium pieces and incubated on an agar culture medium containing malt extract peptone at 26 ° C.

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Pharmacology & Pharmacy (AREA)
• Communicable Diseases (AREA)
• Animal Behavior & Ethology (AREA)
• Oncology (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Plural Heterocyclic Compounds (AREA)
• Agricultural Chemicals And Associated Chemicals (AREA)
• Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Applications Claiming Priority (5)

Publications (1)

Family

ID=26006491

Family Applications (1)

Country Status (11)

Families Citing this family (12)

Family Cites Families (15)

• 2001
  • 2001-07-11 HU HU0301189A patent/HUP0301189A3/hu unknown
  • 2001-07-11 WO PCT/EP2001/007990 patent/WO2002008195A1/de active Application Filing
  • 2001-07-11 EP EP01949488A patent/EP1313709A1/de not_active Withdrawn
  • 2001-07-11 AU AU2001270630A patent/AU2001270630A1/en not_active Abandoned
  • 2001-07-11 PL PL01359809A patent/PL359809A1/xx not_active Application Discontinuation
  • 2001-07-11 JP JP2002514102A patent/JP2004523467A/ja not_active Withdrawn
  • 2001-07-11 BR BR0112927-9A patent/BR0112927A/pt not_active IP Right Cessation
  • 2001-07-11 IL IL15392901A patent/IL153929A0/xx unknown
  • 2001-07-11 CN CNB018161596A patent/CN1222514C/zh not_active Expired - Fee Related
  • 2001-07-11 US US10/333,510 patent/US6992098B2/en not_active Expired - Fee Related
  • 2001-07-11 MX MXPA03000609A patent/MXPA03000609A/es active IP Right Grant
• 2005
  • 2005-02-02 US US11/050,306 patent/US7348350B2/en not_active Expired - Fee Related

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events